Home Medis - Generic Pharmaceuticals and Intellectual Property

Medis - Generic Pharmaceuticals and Intellectual Property

In operation
-
High-Quality Generic Drug Supplier
Basic
Enterprise Profile

Basic Information

Medis is a well-established company focused on high-quality generic drugs. Founded in 1985, they take pride in building strong and lasting business partnerships. Medis leverages the development and manufacturing capabilities of its parent company, Teva Pharmaceutical Industries Ltd., with its R&D experts maintaining a robust development pipeline. Teva (NYSE: TEVA) is a globally leading pharmaceutical company, providing high-quality, patient-centered healthcare solutions to millions of patients daily.
Medis - Generic Pharmaceuticals and Intellectual Property
Iceland
101~500 people
January 01, 1985
medis@medis.is

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Immune Cell Therapy
Technology
Cell Technology
Concept
Therapeutic Products Department of Pharmacy
Application Scenarios
Generic Drug Cell and Gene Therapy